Will you be joining us at #ASH24 in San Diego? As we continue to grow, we’re thrilled to announce our debut exhibition at booth #453. Find out how to connect to treating hematologists in the US and around the world. Reach out and let’s connect: https://lnkd.in/eUnmaV9q #ASH2024
关于我们
We are the global market leader in evidence-based solutions for life science companies seeking to identify, develop, and commercialize oncology and hematology innovations. With a proven track record of success, we transform the world’s growing scientific and clinical knowledge into better patient outcomes. The expertise of our team is backed by unparalleled access to global disease-state experts and healthcare professionals, making Aptitude Health the strategic partner of choice for the world’s most successful life science companies. With a proven track record of success, we transform the world’s growing scientific and clinical knowledge into better patient outcomes. The expertise of our team is backed by unparalleled access to global disease-state experts and healthcare professionals, making Aptitude Health the strategic partner of choice for the world’s most successful life science companies.
- 网站
-
https://aptitudehealth.com
Aptitude Health的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 51-200 人
- 总部
- Atlanta，GA
- 类型
- 私人持股
- 创立
- 2004
- 领域
- Scientific Value Proposition Development、Publication Planning and Management、Strategic Consultancy、Congress Support Services、KOL Development/Management、strategic communication、business intelligence、oncology、hematology、medical communications、market research、promotional services和medical content
地点
Aptitude Health员工
动态
-
Stay ahead with our #BusinessIntelligence reports revealing unmatched viewpoints on present treatments and future therapeutic advances from renowned key opinion leaders and treating physicians. Learn more: https://lnkd.in/erhm9ESx
-
Immune checkpoint inhibitors are a key component of treatment for patients with localized and metastatic #renalcellcarcinoma #RCC #pembrolizumab https://lnkd.in/eVJUw_Yx
-
CORE insights reports are produced from a series of practice-specific community sessions and provide in-depth understanding of patterns of care, disease-state treatment choices, and practice challenges: https://lnkd.in/djwdQEmg
-
You can observe our #SABCS24 conference coverage expert exchange on December 17. Reserve your spot to silently observe and receive the report including tailored expert recommendations: https://lnkd.in/eUnmaV9q #BreastCancer
-
-
Get the rundown on the latest #oncology and #hematology clinical advances. Check out our HemOnc news and sign up for our monthly newsletter: https://lnkd.in/eaGjUdHr
-
-
Meta-analysis results favor neoadjuvant vs adjuvant #immunecheckpointinhibitor therapy in patients with early #breastcancer for improved survival https://lnkd.in/e45Rbw7g
Insights Into Early Breast Cancer Favor Neoadjuvant Immune Checkpoint Inhibitor Therapy - Aptitude Health
-
In December, we are producing insights reports from key data presented at #ASH2024 via several closed-door roundtable meetings with global #hematology experts. Contact us to silently observe the meetings and obtain your copy of the insights reports: https://lnkd.in/eUnmaV9q
-
-
Join us for an exclusive webinar on HR+ #BreastCancer. Discover best practices to enhance patient care from top regional and global experts. Free for HCPs! Register Now: https://lnkd.in/exfbTmWv #CancerCare #BreastCancerCare
-
-
This month we recognize patients, caregivers, physicians, and all those involved in the fight against #LungCancer and #PancreaticCancer. #LungCancerAwarenessMonth #PancreaticCancerAwarenessMonth
-